STVN Earnings

STVN reported its earnings on 2026-05-07, showcasing a revenue of 320.17M against an estimate of 311.41M, resulting in a 2.81% surprise. The EPS was 0.13, surpassing the expected 0.12 by 8.33%. The stock experienced a -5.11% price change on the earnings day and a -4% change over the next five days, reflecting market reactions to the results.

Following STVN's earnings announcement on 2026-05-07, the stock price moved by -5.11% on the day of the release. Over the subsequent five days, it saw a -4% change. Historically, STVN's stock price tends to shift by an average of 1.81% in the 10 days leading up to earnings and -5.94% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate STVN's annual revenue to reach 305.04M, while the EPS is projected at 0.17. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between STVN's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, STVN's stock price typically moves by 1.81% in the 10 days before its earnings and -5.94% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 0.17 and revenue of 305.04M.

The earnings call reveals a mixed outlook. While there are positive signs such as margin expansion, strong biologics growth, and strategic capacity investments, there are also concerns about slower order materialization in the Engineering segment, inflationary pressures, and a lack of clarity in management's responses. The lack of new partnerships or significant shareholder return plans, along with no clear guidance changes, suggests a neutral sentiment. Without market cap data, the prediction remains neutral, assuming average volatility.